Louis Drapeau

Louis Drapeau has considerable expertise in both the biotech sector and the financial rigour required of US public companies. Based in the US, Mr Drapeau is an independent director at AmphliPhi Biosciences Corporation (NYSE); chief financial officer, principal accounting officer and vice president at Insite Vision; and independent director of at Bio-Rad Laboratories (NYSE). Mr Drapeau held senior positions with Nektar Therapeutics and BioMarin Pharmaceutical, and has been an audit partner at Arthur Andersen. Mr Drapeau has also been an independent director at InterMune (NASDAQ), Bionovo (NASDAQ), and Inflazyme Pharmaceuticals (TSE). He has an MBA from Stanford University.
Bio last updated 02 Jun 2017

Article Timeline

Access to our data for Louis Drapeau is only available to paid subscribers with access.

The search engine is Western Australia's most accurate and comprehensive business listings and searchable database.

Louis Drapeau is linked to 1 organisation which is included in 1 list - Public Companies - Industrial.

To see the data you will need to .

Total Shareholder Return as at 31/12/18

1 year TSR5 year TSR
110thAvita Medical29%-7%
487thHolista Colltech-33%-10%
506thRefresh Group-37%9%
579thWestStar Industrial-47%-56%
732ndAdvanced Braking Technology-67%-34%
716 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar


Non-Executive Director
Year started and most recent title


86th↑Avita Medical$11.3m
89th↑WestStar Industrial$9.1m
90th↓Refresh Group$8.8m
92nd↑Holista Colltech$8.0m
93rd↓Advanced Braking Technology$7.9m
237 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer